Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on lewis acid catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115785122A details a novel Sc(OTf)3-catalyzed synthesis of indole-derived piperidines with high cytotoxicity, offering a scalable route for reliable pharmaceutical intermediate suppliers.
Novel bismuth-catalyzed route offers high yields and recyclability for asymmetric triarylmethane derivatives, reducing costs in pharmaceutical intermediate manufacturing.
Patent CN111978265B details a cost-effective FeCl3-catalyzed route for 5-trifluoromethyl-1,2,4-triazoles, offering significant supply chain advantages for API manufacturers.
Novel acid-catalyzed cyclization for fused biindoles. Mild conditions, high purity, scalable process for pharmaceutical intermediates and drug discovery.
Patent CN114456089B details a novel cobalt-catalyzed three-component reaction enabling efficient synthesis of amino-nitrile pharmaceutical intermediates with reduced costs.
Novel AlCl3-catalyzed route offers high stereoselectivity and mild conditions for scalable production of key pharmaceutical intermediates.
Discover the novel Sc(OTf)3-catalyzed synthesis of indole-derived piperidines. A cost-effective, high-yield route for anticancer pharmaceutical intermediates with superior diastereoselectivity.
Patent CN102464613A reveals a mild, high-yield quinoline synthesis using Lewis acids and oxidants. Ideal for reliable pharmaceutical intermediate suppliers seeking cost reduction.
Patent CN107021866A details a Lewis acid catalyzed route for chain enyne compounds. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel AlCl3-catalyzed route offers high Z-selectivity and mild conditions for scalable phthalide intermediate manufacturing.
Novel synthetic route for 5-hydroxy-1-indenones offering high selectivity and scalable production for pharmaceutical intermediates supply chain optimization.
Patent CN112159312B reveals a mild one-pot synthesis for triarylmethanes. This method offers high yields and simplified purification for reliable pharmaceutical intermediate supply chains.
Novel two-step route for o-alkynyl phenylcyclobutanone and naphthalenone synthesis offering high yield and scalability for pharma applications.
Novel synthesis route avoids explosive diazo compounds, offering high purity and scalable production for pharmaceutical intermediates globally.
Patent CN107382741B details a high-yield B(C6F5)3 catalyzed hydroamination. Offers cost-effective, scalable routes for pharmaceutical intermediates with minimal impurities.
Novel patent CN119504713A reveals efficient synthesis of indole-pyrrole tetraarylmethane. Offers cost reduction and scalable supply for pharmaceutical intermediates.
Patent CN104520275B details a novel route for 4-oxoquinolone compounds, offering improved stability and cost-effective manufacturing for HIV integrase inhibitor supply chains.
Novel one-pot Lewis acid catalysis achieves >90% yield for indaneamine, enabling sustainable agrochemical manufacturing with reduced waste and reliable supply chain solutions.
Patent CN113527177B introduces a safe catalytic route eliminating explosive reagents for gem-difluoroolefin intermediates enabling enhanced supply chain reliability and significant cost reduction in pharmaceutical manufacturing.
Patent CN113527177B enables scalable production of high-purity fluorinated intermediates through safe synthesis without explosive reagents offering significant cost reduction in pharmaceutical manufacturing supply chains